NewClin is a e-health startup company being created in Lyon, France. We develop and commercialize transforming solutions based upon data and technologies for the acceleration and productivity of clinical research. Our ultimate goal is to ease access to therapeutic innovation for all, everywhere. At birth, one can expect to spend close to 20 cumulated years in bad health, on average. This raises the question of accessing the best therapies whenever necessary, particularly in the case of serious, rare and/or orphan diseases and/or when treatment cost is high. Clinical research is a way to benefit from therapeutic innovation. But 4 out of 5 clinical trials are delayed, mostly due to a lack of patient enrolment. This induces massive costs for study sponsors and postpones the opportunity, for physicians and patients, to access new therapies. This is why NewClin develops two data- and technology-based solutions: - The most comprehensive mobile apps suite for the acceleration and productivity of clinical research - The first and unique global, multilingual platform for an early, free and personalized access to therapeutic innovation through clinical research You are a lifescience company, a CRO, an academic organization, a clinical site or an institution and you want to transform your clinical research activity? Contact us!